Skip to main content

ArcticZymes Technologies

ArcticZymes Technologies ASA is a Norwegian life science company developing cold-adapted enzymes for molecular diagnostics, RNA therapeutics, and synthetic biology. The company discovers, manufactures, and markets marine-derived enzymes including Cod UNG, SAN, and Salt Active Nuclease, utilized to eliminate DNA contamination and facilitate nucleic acid workflows. Main revenue drivers consist of B2B commercial sales of enzyme reagents and custom formulation fees billed to biopharmaceutical and diagnostic firms. ArcticZymes Technologies serves molecular diagnostic developers, vaccine manufacturers, cell and gene therapy companies, and academic research institutions in North America, Europe, and Asia. The company holds a specialized market position in cold-adapted enzyme development for life science applications. Headquartered in Tromso, Norway, it is listed on Oslo Bors.

3 of the funds FundTelligence covers report a position in ArcticZymes Technologies.

Legal name
ArcticZymes Technologies ASA
Sector
Health Care
Country
Norway
Funds holding it
3

Funds holding ArcticZymes Technologies

Loading...